Subcutaneous low-dose azacitidine as maintenance therapy following hematopoietic stem cell transplantation for acute myeloid leukemia and high-risk myelodysplastic syndrome¿A propensity score matched analysis André Dias Américo; Cinthya Correa Silva; Mariana Nassif Kerbauy; Leonardo Javier Arcuri; Andressa Alice Feitosa Ribeiro; Nelson Hamerschlak; Fábio Pires Souza Santos;